Neogen Chemicals Limited

Chemicals: Specialty/ NSE

Compiled

Auto-generated from filings and public channels — no analyst dossier.

If management delivers what it guided

arithmetic on filed guidance and past valuations · not a price target

NEOGEN

FY26 → FY27 · 1 year of guidance · ~0.7 years from today₹2,023 today

BEAR

₹724

-64%

3.4% a year · 64.2x exit

BASE

₹1,107

-45%

5.9% a year · 96x exit

BULL

₹1,359

-33%

8% a year · 115.5x exit

Where the market has priced it

28x186x today — outside the range123x

at 186x its FY26 earnings the stock already trades above the top of its own ten-year range (115x)
this company's own median multiple sits 324% above its filed-industry peers; the scenario uses its own

How these numbers are produced

Earnings base	FY26 fiscal year EPS ₹10.9 (screener)
Guided growth	5.9% a year, said on the call of 25-May-2026 · transcript
Read across as	operating: absolute ₹ revenue target — medium confidence
Delivery calibration	0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings
Exit multiple	64.25x / 96x / 115.48x, this company’s own p20 / median / p80 across 7 filed years
Filed-industry peers	median 22.65x across 40 peers — the cross-check, not the input
Arithmetic	base EPS × (1 + guided growth × delivery)¹ × exit multiple

Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.

How to read this

It answers one question. If this management delivers the growth it told its own investors it would, and the market pays what it has historically paid for this company's earnings, where does the arithmetic land? Nothing here is a forecast of the share price.
Three cases, two moving parts. Bear, base and bull vary the delivery — what fraction of guidance managements actually file — and the exit multiple together, because a company that misses its guidance is usually de-rated for missing it. Each case shows the growth rate and the multiple that produced it.
Read the width, not just the middle. A wide gap between bear and bull means the inputs are uncertain, not that the upside is bigger. A narrow range is a more confident statement than a high one.
“Where the market has priced it” puts today's P/E on the company's own historical range. Sitting far below that range is why a scenario can look enormous: the number is then mostly about re-rating, not about delivery, and the board marks those separately.
The bullets underneath are the caveats — a borrowed peer multiple, a thin filed history, an earnings base that carried a one-off. They are the reasons to trust the number less, listed rather than buried.

Not a price target, not a recommendation, and not a forecast of what the stock will do. The field guide covers the method.

What management said

from a third-party research digest · not our own extraction

implied earnings growth 6%

Revenue guidance for FY27 revised to INR 875-950 crore due to delayed Dahej plant commissioning (Source 1, May 2026).

Call 25-May-2026 · bridge confidence medium · transcript PDF

Coverage

SectorChemicals: Specialty

Dossiersnone

Guidanceyes

Scenarioyes

Street chatter

unverified · logged from public channels

Namo eWaste — 40–50% growth for next 2 years

TARIL — 40%+ growth for next 3 years

Neogen Chemicals — 40%+ growth for next 3–4 years

50%+ Growth

NEOGEN CHEMICALS : SUBSIDIARY NIL TO INVEST ₹100.11 CR IN STEP-DOWN SUBSIDIARY NML FOR LITHIUM-ION BATTERY ELECTROLYTE SALTS 🔋⚗️

28 Apr 13:08

HDFC Bank – US$1 billion AT-1 bond redemption.

ICICI Bank – Investment-grade rating.

Neogen Chemicals – ₹600 crore QIP. *(Specialty Chemicals)*

Capital action27 Jul 03:11

Neogen Chemicals sets dividend record date and book closure. #NEOGEN - 1 minute ago

AI-curated filing alert · Not investment advice

Capital action30 Jul 18:14